Financial Summary for Fiscal Year Ended August 2026 and Full-Year Forecast for Fiscal Year Ending August 2027

Overview of Results

For the fiscal year ended August 2026, consolidated results were: revenue 17,205 hundred million yen (YoY +1.3%), gross profit 6,887 hundred million yen, operating income 3,625 hundred million yen, ordinary income 3,835 hundred million yen, and net income attributable to owners of parent 2,660 hundred million yen. While core markets remained solid, a decline in patient wear negatively impacted results. A recovery is expected in 4Q, securing full-year revenue growth. Growth in overseas markets and contributions from higher value-added products provided support.

Outlook and Shareholder Returns

The full-year forecast for the fiscal year ending August 2027 is revenue 17,500 hundred million yen (YoY +1.7%), operating income 3,602 hundred million yen, ordinary income 3,893 hundred million yen, and net income attributable to owners of parent 2,660 hundred million yen. The company plans to continue growth in core and overseas markets and to accelerate renewal projects through new product launches such as the miffy brand. Shareholder returns will maintain stable dividends with a target payout ratio of approximately 50%. Share buybacks will also continue, and the current acquisition period is ongoing for this fiscal year.